Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by tdon1229on Jan 12, 2021 1:29pm
152 Views
Post# 32277070

RE:NCATS drug screening for effectiveness vs. Covid virus

RE:NCATS drug screening for effectiveness vs. Covid virus

tdon1229 wrote: NCATS, an arm of the US NIH, has been screening drugs for their effectiveness (in vitro) vs. the Covid virus.  They claim to have screened approximately 10,000 drugs thus far.

Here's a link to their portal where you can look through the 225 pages of screening results or type a drug name/designation into the box at upper left to search for your drug of choice.  I didn't find any results there for the drug that brings us to this board, but younger eyes with more time might find it hidden there. 

https://opendata.ncats.nih.gov/covid19/databrowser?q=rose%20bengal%20disodium


 

Further to the above ...

The OpenData COVID-19 portal is a resource designed to rapidly and openly share SARS-CoV-2 screening data and assay information with the global health community, according to NIH-subdivision NCATS. Scientists there have been working to develop a number of SARS-CoV-2-related assays to measure over 10,000 compounds, including the NCATS Pharmaceutical Collection of nearly 3,000 approved drugs, for their activity against the virus.

<< Previous
Bullboard Posts
Next >>